ClinicalTrialsFinder

HR-positive,HER2-negative Breast Cancer Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

HR-positive,HER2-negative Breast Cancer
First Affiliated Hospital of Zhejiang University30 enrolled1 locationNCT06705127